Analytical Data
-
基因名
MDC
- Application
-
别名
MDC；MDC；SCYA22；C-C motif chemokine 22
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O00626
-
表达区间
25-93aa
-
氨基酸序列
GPYGANMEDSVCCRDYVRYRLPLRVVKHFYWTSDSCPRPGVVLLTFRDKE ICADPRVPWVKMILNKLSQ
-
分子量
8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MDC (Monocyte-Derived Chemokine) recombinant protein research has gained significant attention due to its potential role in immune modulation and inflammatory responses. MDC is a cytokine that plays a crucial part in the migration and activation of immune cells, particularly monocytes, which are pivotal in the body's defense mechanisms. The recombinant production of MDC facilitates the investigation of its biological functions and therapeutic applications, especially in conditions such as chronic inflammation, autoimmune diseases, and cancer. The ability to produce MDC in a controlled and scalable manner allows researchers to study its signaling pathways, interactions with other immune mediators, and its effects on different cell types. Furthermore, understanding the mechanistic role of MDC in disease processes can pave the way for the development of novel therapeutic strategies targeting MDC pathways, with the potential to improve patient outcomes in various pathological conditions. As such, the study of MDC recombinant proteins is not only critical for advancing our knowledge of immune responses but also for exploring new avenues in immunotherapy and personalized medicine.
